Filtered By:
Infectious Disease: Pandemics
Management: WHO
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 113 results found since Jan 2013.
Grace Under Pressure: Resiliency of Quality Monitoring of Stroke Care During the Covid-19 Pandemic in Mexico City
Stroke is one of the leading causes of death and disability among adults worldwide. The World Health Organization (WHO) officially declared a COVID-19 pandemic on March 11, 2020. The first case in Mexico was confirmed in February 2020, subsequently becoming one of the countries most affected by the pandemic. In 2020, The National Institute of Neurology of Mexico started a Quality assurance program for stroke care, consisting of registering, monitoring and feedback of stroke quality measures through the RES-Q platform. We aim to describe changes in the demand for stroke healthcare assistance at the National Institute of Neu...
Source: Frontiers in Neurology - April 6, 2022 Category: Neurology Source Type: research
Ditching masks at a stroke is too much too soon
Responding to the Prime Minister’s announcement ending rules requiring face coverings in enclosed public spaces, UNISON assistant general secretary Jon Richards said today (Monday):
“This isn’t the time to throw caution to the wind, especially with infections on the rise. The economy is important, but so is public confidence.
“These hasty changes will create a confusing cocktail of guidance. The public will be expected to know how to react to each and every situation they face.
“Pressure is already building on ambulance and other NHS services, and that’s before safety measures are ditched. It’s just to...
Source: UNISON meat hygiene - July 5, 2021 Category: Food Science Authors: Anthony Barnes Tags: News Press release face coverings pandemic Source Type: news
COVID-19 induced ischemic stroke and mechanisms of viral entry in brain and clot formation: a systematic review and current update
Conclusion: Data available in the literature is not adequate to come to a conclusion. Therefore, there is a need to carry out further studies to delineate the possible association between SCV-2 induced IS.PMID:35412938 | DOI:10.1080/00207454.2022.2056460
Source: Atherosclerosis - April 12, 2022 Category: Cardiology Authors: Abhilash Ludhiadch Swaraj Ranjan Paul Rahul Khan Anjana Munshi Source Type: research
Measurement of the potential geographic accessibility from call to definitive care for patient with acute stroke
The World Health Organization refers to stroke, the second most frequent cause of death in the world, in terms of pandemic. Present treatments are only effective within precise time windows. Only 10% of thromb...
Source: International Journal of Health Geographics - January 12, 2018 Category: International Medicine & Public Health Authors: J. Freyssenge, F. Renard, A. M. Schott, L. Derex, N. Nighoghossian, K. Tazarourte and C. El Khoury Tags: Research Source Type: research
Patent Foramen Ovale related cryptogenic stroke during COVID-19 disease in three patients: a case series
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), termed COVID-19, first detected in Whuan, was officially declared a pandemic by the World Health Organization on March 11, 2020. The epidemic of COVID-19 has rapidly spread worldwide. Italy was the first European country to be affected and, currently, Italy has reported 4,343,397 COVID-19-positive cases (1).
Source: Journal of Stroke and Cerebrovascular Diseases - September 13, 2021 Category: Neurology Authors: Daniela Palleri, Marta Guidarini, Elisabetta Mariucci, Anna Balducci, Gabriele Egidy Assenza, Susanna Esposito, Andrea Donti Source Type: research
Neurological Manifestations in Patients with COVID-19: Experiences from the Central Infectious Diseases Hospital in South Korea
CONCLUSIONS: Neurological manifestations were commonly observed in patients with COVID-19. During the current pandemic, when patients present with new-onset neurological symptoms, COVID-19 may be considered as part of the differential diagnosis. Attention to severe neurological complications is needed, especially in patients with severe or critical COVID-19.PMID:34184452 | DOI:10.3988/jcn.2021.17.3.435
Source: Journal of Clinical Neurology - June 29, 2021 Category: Neurology Authors: Hyun Kyung Kim Yeo Jeong Cho Seo Young Lee Source Type: research
